CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease
CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease
isPeerReviewed
abstract
<p>BACKGROUND: Dysregulation o ...... eurodegenerative diseases.</p>
@en
authorList
type
label
CERTL reduces C16 ceramide, am ...... a model of Alzheimer's disease
category
electronicVersions
journalAssociation
journalNumber
language
managingOrganisationalUnit
openAccessPermission
organisationalUnits
publicationStatuses
submissionYear
totalScopusCitations
visibility
Publiek - Geen beperking
@nl
workflow
Validated
@en